Profusa (PFSA) Long-Term Investments (2021 - 2025)
Profusa's (PFSA) quarterly Long-Term Investments came in at $661012.0 in Q2 2025, down 92.2% year-on-year from $8.5 million in Q2 2024, and down 54.49% quarter-over-quarter from $1.5 million in Q1 2025.
Profusa (PFSA) Long-Term Investments (2021 - 2025) Analysis & Trends
Profusa's Long-Term Investments history runs 5 years deep, the most recent figure standing at $661012.0 for Q2 2025.
- On a quarterly basis, Long-Term Investments fell 92.2% year-over-year to $661012.0 in Q2 2025; TTM through Jun 2025 was $661012.0, a 92.2% decrease from a year earlier, with the FY2024 full-year figure at $8.3 million, up 432.3% from the prior year.
- Long-Term Investments retreated to $661012.0 in Q2 2025 per PFSA's latest filing, from $1.5 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $194.2 million in Q4 2022 and bottomed at $595439.0 in Q3 2024.
- The 5-year median for Long-Term Investments is $10.4 million (2023), against an average of $68.2 million.
- Across the five-year window, Long-Term Investments plunged 99.19% in 2023 and jumped 432.3% in 2024, its largest moves.
- Year by year, Long-Term Investments stood at $191.7 million in 2021, then grew by 1.34% to $194.2 million in 2022, then plunged by 99.19% to $1.6 million in 2023, then soared by 432.3% to $8.3 million in 2024, then tumbled by 92.07% to $661012.0 in 2025.
- Per Business Quant, the three latest PFSA Long-Term Investments figures stand at $661012.0 (Q2 2025), $1.5 million (Q1 2025), and $8.3 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 166.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 121.00 Mn |
| 10 | Profusa | 23,566.40 | -351,433.60 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 661,012.00 |
| Mar 31, 2025 | 1.45 Mn |
| Dec 31, 2024 | 8.33 Mn |
| Sep 30, 2024 | 595,439.00 |
| Jun 30, 2024 | 8.48 Mn |
| Mar 31, 2024 | 8.43 Mn |
| Dec 31, 2023 | 1.57 Mn |
| Sep 30, 2023 | 10.65 Mn |
| Jun 30, 2023 | 10.66 Mn |
| Mar 31, 2023 | 10.39 Mn |
| Dec 31, 2022 | 194.22 Mn |
| Sep 30, 2022 | 193.02 Mn |
| Jun 30, 2022 | 191.88 Mn |
| Mar 31, 2022 | 191.73 Mn |
| Dec 31, 2021 | 191.65 Mn |